Delphi Consensus Excessive Daytime Sleepiness in OSA
Differential Diagnosis and Management of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea: A Modified Delphi Consensus Panel Report
1 other identifier
observational
10
1 country
1
Brief Summary
The objective of this study is to generate expert consensus statements on the differential diagnosis, definition, and management of EDS in patients with OSA who are adequately treated with primary therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 7, 2021
CompletedFirst Posted
Study publicly available on registry
September 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2022
CompletedOctober 10, 2023
October 1, 2023
1.4 years
September 7, 2021
October 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Consensus
The level of agreement for all statements achieving consensus from the expert panel; consensus is predefined as ≥ 80% of the panel rating a given statement A+ or A.
6 months
Study Arms (1)
Delphi panel
The Delphi panel will include 10 international experts in sleep and respiratory medicine. Two panelists will serve as co-chairs and eight panelists will serve as section leads for the major topic areas throughout the process. A series of planning sessions will be conducted with the co-chairs and section leads prior to implementation of the survey.
Eligibility Criteria
Experts in sleep and respiratory medicine from North America and Europe
You may qualify if:
- Members of the panel include experts in sleep and respiratory medicine in North American and Europe.
You may not qualify if:
- Panelists who were not able to commit to all rounds of the modified Delphi process will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- Jazz Pharmaceuticalscollaborator
Study Sites (1)
King's College London
London, SE1 7EH, United Kingdom
Related Publications (1)
Rosenberg R, Schweitzer PK, Steier J, Pepin JL. Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management. Postgrad Med. 2021 Sep;133(7):772-783. doi: 10.1080/00325481.2021.1948305. Epub 2021 Jul 22.
PMID: 34292843BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Joerg Steier, PhD
King's College London (KCL), UK
- STUDY CHAIR
Atul Malhotra, MD
University of California San Diego (UCSD), USA
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Respiratory and Sleep Medicine
Study Record Dates
First Submitted
September 7, 2021
First Posted
September 24, 2021
Study Start
April 1, 2021
Primary Completion
September 12, 2022
Study Completion
September 12, 2022
Last Updated
October 10, 2023
Record last verified: 2023-10